These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21183492)

  • 21. Abdominal complications of chemotherapy: findings at computed tomography.
    Liu YI; Jha P; Wang ZJ; Yeh BM; Poder L; Westphalen AC; Coakley FV
    Clin Imaging; 2012; 36(1):54-60. PubMed ID: 22226444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Targeted therapies: towards a new toxicology?].
    Aissi S; Ben Mrad M; Zarraa S; Bounedjar A; Laabidi S; Boussen H
    Pathol Biol (Paris); 2012 Aug; 60(4):234-8. PubMed ID: 22743098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal variants and pitfalls in CT of the gastrointestinal and genitourinary tracts.
    Akbar SA; Shirkhoda A; Jafri SZ
    Abdom Imaging; 2003; 28(1):115-28. PubMed ID: 12483399
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapy induced liver abnormalities: an imaging perspective.
    Sharma A; Houshyar R; Bhosale P; Choi JI; Gulati R; Lall C
    Clin Mol Hepatol; 2014 Sep; 20(3):317-26. PubMed ID: 25320738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT of the urinary tract: turning attention to radiation dose.
    Kalra MK; Singh S; Blake MA
    Radiol Clin North Am; 2008 Jan; 46(1):1-9, v. PubMed ID: 18328876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isotope studies in children: an update.
    Siddiqui AR
    Semin Pediatr Surg; 1992 Nov; 1(4):245-52. PubMed ID: 1345492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary toxicities of molecular targeted antineoplastic agents: a single-center 10-year experience.
    Lee MY; Yoon SY; Kim KH; Lee N; Kim HY; Hwang JH; Won JH
    Korean J Intern Med; 2021 May; 36(3):689-698. PubMed ID: 33412778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary drug toxicity: radiologic and pathologic manifestations.
    Rossi SE; Erasmus JJ; McAdams HP; Sporn TA; Goodman PC
    Radiographics; 2000; 20(5):1245-59. PubMed ID: 10992015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I trials of molecularly targeted agents: should we pay more attention to late toxicities?
    Postel-Vinay S; Gomez-Roca C; Molife LR; Anghan B; Levy A; Judson I; De Bono J; Soria JC; Kaye S; Paoletti X
    J Clin Oncol; 2011 May; 29(13):1728-35. PubMed ID: 21444876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging of complications of oncological therapy in the gastrointestinal system.
    Viswanathan C; Bhosale P; Ganeshan DM; Truong MT; Silverman P; Balachandran A
    Cancer Imaging; 2012 May; 12(1):163-72. PubMed ID: 22571819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of cancer chemotherapy.
    Sunnenberg TD; Kramer B
    Compr Ther; 1985 Sep; 11(9):58-67. PubMed ID: 4042597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment and management of gastrointestinal toxicities and lab abnormalities related to targeted therapy.
    Fischer-Cartlidge EA
    Semin Oncol Nurs; 2014 Aug; 30(3):183-9. PubMed ID: 25085030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast media for fluoroscopic examinations of the GI and GU tracts: current challenges and recommendations.
    Federle MP; Jaffe TA; Davis PL; Al-Hawary MM; Levine MS
    Abdom Radiol (NY); 2017 Jan; 42(1):90-100. PubMed ID: 27503380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of chemotherapy toxicities.
    Peters BG
    Top Hosp Pharm Manage; 1994 Jul; 14(2):59-88. PubMed ID: 10136204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer therapy-related complications in the bowel and mesentery: an imaging perspective.
    Gray EJ; Darvishzadeh A; Sharma A; Ganeshan D; Faria SC; Lall C
    Abdom Radiol (NY); 2016 Oct; 41(10):2031-47. PubMed ID: 27277528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic disorders associated with the use of targeted cancer therapies.
    Kotecki N; Penel N; Awada A
    Curr Opin Oncol; 2015 May; 27(3):258-66. PubMed ID: 25730544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onconephrology: What Should the Internist Know About Targeted Therapy in Solid Tumors?
    El Rassy E; El Karak F; Rizkallah J; Chelala D
    Iran J Kidney Dis; 2016 Jul; 10(4):169-75. PubMed ID: 27514761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Society of Abdominal Radiology Disease-Focused Panel Program: rationale for its genesis and status report.
    Silverman SG; Megibow AJ; Fletcher JG
    Abdom Radiol (NY); 2017 Aug; 42(8):2033-2036. PubMed ID: 28349224
    [No Abstract]   [Full Text] [Related]  

  • 40. Ophthalmic complications of targeted cancer therapy and recently recognized ophthalmic complications of traditional chemotherapy.
    Kheir WJ; Sniegowski MC; El-Sawy T; Li A; Esmaeli B
    Surv Ophthalmol; 2014; 59(5):493-502. PubMed ID: 25130892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.